First time users: You will need to check your degree as you created an ACMG account. The system designates educational credits according to your degree. Be sure you are logged in (do you see your name on the top right under the ACMG Genetics Academy logo?). If not, log in before proceeding.

For technical support, please send an email to: education@acmg.net  or call 301-718-9603.

Or click on the "Help"  icon on the left-hand side of your screen for more information.

Evidence Based Guidelines Webinar 201: Exome and Genome Sequencing for Pediatric Patients with Congenital Anomalies or Intellectual Disability

Date of Release: July 27, 2022

Expiration Date: July 31, 2024

Credits offered: CME, NSGC Category 2 (Self-report)

Estimate time of completion: 1 hour per webinar

Course must be completed by the expiration date

Series Information:

The Evidence-Based Guidelines Webinar Series, supported by the National Coordinating Center for the Regional Genetics Networks (NCC) and ACMG, is a two-part webinar series for each of the ACMG Evidence-Based Guidelines that will provide an overview and application of the evidence-based guideline (101) and then provide a deeper-diver into the evidence used to support the recommendation (201).

Session Information:

Exome and Genome Sequencing for Pediatric Patients with Congenital Anomalies or Intellectual Disability, join us for a one-hour webinar that will explore in detail the evidence used in the review process, how the evidence was translated into a recommendation using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework, and how the guideline can implemented in genetics and non-genetics practice.

Learning Objectives:

At the conclusion of this session, participants should be able to:

1. Explain the general framework used to develop the recommendation.
2. Describe two pieces of evidence used to support the recommendation.
3. Identify patients that may benefit from exome or genome sequencing and when in the diagnostic workup exome or genome sequencing should be considered.

Target Audience:

Healthcare Providers (genetics providers, non-genetics providers who have attended the 101 webinar, healthcare providers who manage patients with congenital anomalies and/or intellectual disabilities).

Presenters:

Laurie Demmer, MD, FACMG

Chief of Genetics and Metabolism at Atrium Health's Levine Children's Hospital

Fuki Hisama, MD, FACMG, FAAN

Professor of Medicine (Division of Medical Genetics)

Seattle Cancer Care Alliance

Planning Committee:
Laurie Demmer, MD, FACMG
Fuki Hisama, MD, FACMG, FAAN

Megan Lyon, MPH

Jennifer Malinowski, MS, PhD

Murugu Manickam, MD, FACMG

Jane Radford, MHA, CHCP

Accredited Continuing Education Information:

Continuing Medical Education (CME AMA & CME Other)

Accreditation
The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Society of Genetic Counselors (NSGC Self-report)

This activity meets requirements to apply for Category 2 CEUs from the National Society of Genetic Counselors (NSGC). Please complete the evaluation and submit your certificate to NSGC, using the instructions for “How To Submit a Category 2 CEU Application in the NSGC CEU Portal.” ACMG is the accredited sponsor. You must apply within 30 days of the activity date. NSGC will charge a processing fee of $25 for this activity. ACMG does not report attendance to NSGC for this activity.

Claiming your Educational Credits

This activity consists of: View content, take a post-test, the test may be taken as often as necessary to achieve a passing score of 80% or better is required to receive credit. If you do not achieve a passing score, the program will identify which questions you answered incorrectly so that you can review the module and try again. Complete the evaluation form.

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice. ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.

*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACMG Education Policies

Please review the policies below regarding the ACMG Education program

• Financial Disclosures and Mitigation Procedure
• ACMG Content Validation Policy
• ACMG Content Branding Policy